香港 2025年6月24日 /美......" /> 成人av日韩一区,成人动漫午夜精品一区网站,人妻少妇久久精品无码

国产一级毛卡片视频在线播放,成人电影免费看,欧美精品日韩一区二区,日本福利视频在线,天天综合网加勒比

from common-pcom:html:key:hk_segment_includes_overall_segment_header_shtml
美通社: 全球領(lǐng)先的新聞稿發(fā)佈, 傳播和監(jiān)測(cè)服務(wù)提供者
首頁(yè) > 新聞稿中心 > 行業(yè)新聞稿
zh_TW

全新SKINVIVE? 昇光針? 矚目登場(chǎng) -- 引領(lǐng)突破水光界限

2025-06-24 18:02

邂逅肌膚原生美肌  隨時(shí)奢享昇光自由

按此連結(jié)下載高清圖片:(https://bit.ly/446KV5I)

香港 2025年6月24日 /美通社/ -- 全球醫(yī)學(xué)美容領(lǐng)導(dǎo)廠商 Allergan Aesthetics 引領(lǐng)突破水光界限,隆重宣佈全新品牌SKINVIVE® 昇光針® 強(qiáng)勢(shì)登陸。與此同時(shí),我們也非常高興宣佈著名演員蔡思韻(Cecilia)成為SKINVIVE® 昇光針® 的品牌代言人,攜手揭秘巔峰醫(yī)美話題新作,呈現(xiàn)給您看得見的彈、滑、亮1-2,賦活全方位的肌底「源」動(dòng)力,膚質(zhì)進(jìn)階、昇光無(wú)瑕!

全球醫(yī)學(xué)美容領(lǐng)導(dǎo)品牌Allergan Aesthetics宣布著名演員蔡思韻(Cecilia)成為 SKINVIVE® 昇光針® 的最新品牌代言人。
全球醫(yī)學(xué)美容領(lǐng)導(dǎo)品牌Allergan Aesthetics宣布著名演員蔡思韻(Cecilia)成為 SKINVIVE® 昇光針® 的最新品牌代言人。

與她一起煥啟肌源年輕    深透昇光肌

作為影視界的實(shí)力派演員,Cecilia 蔡思韻以獨(dú)特的氣質(zhì)和細(xì)膩專業(yè)的表演方式,吸引了無(wú)數(shù)觀眾。清新脫俗的氣質(zhì)和她的優(yōu)雅與誠(chéng)摯恰好詮釋了SKINVIVE® 昇光針® 強(qiáng)調(diào)肌膚原生之美的理念。

對(duì)她而言,皮膚水份不足會(huì)引起一連串的肌膚問(wèn)題,因此護(hù)膚保濕是日常不可或缺。難怪鏡頭下的Cecilia每一幀都是高光透亮的狀態(tài),整天光彩照人! Cecilia亦深明護(hù)膚保養(yǎng)是全方位的,日常的飲食、健康生活固然重要,配合有效的醫(yī)美膚質(zhì)管理皆不能少。這亦是 Cecilia 答應(yīng)擔(dān)任SKINVIVE® 昇光針® 代言人的原因 ,而其品牌的3 大亮點(diǎn) — 高效可靠、 節(jié)省時(shí)間、一次到位更是值得信賴!

蔡思韻(Cecilia)以其清新脫俗的氣質(zhì),完美演繹 SKINVIVE® 昇光針® 的原生美肌理念,其高效、省時(shí)、一次到位的三大亮點(diǎn),絕對(duì)值得信賴!
蔡思韻(Cecilia)以其清新脫俗的氣質(zhì),完美演繹 SKINVIVE® 昇光針® 的原生美肌理念,其高效、省時(shí)、一次到位的三大亮點(diǎn),絕對(duì)值得信賴!

唯一獲得雙重國(guó)際認(rèn)證  ︳煥發(fā)6大新生「肌」準(zhǔn)

SKINVIVE® 昇光針® 為第一及唯一獲得美國(guó)FDA及歐盟CE雙重認(rèn)證3-4的透明質(zhì)酸水光品牌,於法國(guó)製造,使用全球No.1品牌5Juvéderm® 喬雅登® 的國(guó)際專利技術(shù)6,確保與肌膚組織融合度佳6,效果更自然持久6

一般護(hù)膚品的透明質(zhì)酸,大多只能針對(duì)皮膚表層保濕7,而SKINVIVE® 昇光針® 專爲(wèi)還原健康膚質(zhì)健康而設(shè),其透明質(zhì)酸質(zhì)感較輕薄7,能夠輕鬆滲入肌底8-9深透肌膚真皮層10*,從根源補(bǔ)濕10,並撫平細(xì)紋11,煥發(fā)6大新生「肌」準(zhǔn)1,10 —— 水潤(rùn)?、清透?提亮§、順滑、均勻色澤細(xì)緻毛孔**,重拾健康水潤(rùn)光澤感,與您一同踏上原生昇光之旅。

SKINVIVE® 昇光針® 是首個(gè)且唯一獲得美國(guó)FDA及歐盟CE雙重國(guó)際認(rèn)證的透明質(zhì)酸水光品牌,法國(guó)製造並採(cǎi)用 Juvéderm® 喬雅登® 專利技術(shù),確保自然持久,煥發(fā)六大新生「肌」準(zhǔn)。
SKINVIVE® 昇光針® 是首個(gè)且唯一獲得美國(guó)FDA及歐盟CE雙重國(guó)際認(rèn)證的透明質(zhì)酸水光品牌,法國(guó)製造並採(cǎi)用 Juvéderm® 喬雅登® 專利技術(shù),確保自然持久,煥發(fā)六大新生「肌」準(zhǔn)。

唯一透明質(zhì)酸水光療程帶來(lái)最長(zhǎng)效果   ︳ 輕鬆擺脫繁複護(hù)膚步驟

締造健康透亮的肌膚,必須從源頭開始,由內(nèi)而外煥活肌膚。SKINVIVE® 昇光針® 能夠提升細(xì)胞水通道(AQP3)12,釋放長(zhǎng)效^深層*水潤(rùn)?之餘,讓水分從水通道帶到表層12,有助恢復(fù)肌膚屏障功能及彈性活力13??蒲袑?shí)證一次持效長(zhǎng)達(dá)9個(gè)月10,14^,超過(guò)96% 用家表示療程後見證肌膚更顯細(xì)滑??,對(duì)膚質(zhì)及光澤感提升了3倍滿意度??,更滿意自己膚質(zhì)1。只需大約10-15分鐘15, 即可重拾健康肌膚,打好護(hù)膚基礎(chǔ)。

全新SKINVIVE® 昇光針® 重塑水光巔峰,讓肌膚由內(nèi)而外煥亮發(fā)光。有關(guān)療程詳細(xì)內(nèi)容及價(jià)格,請(qǐng)向各大原廠供應(yīng)的醫(yī)療中心查詢。

關(guān)於Allergan Aesthetics*

作為全球醫(yī)學(xué)美容領(lǐng)導(dǎo)廠商,Allergan Aesthetics致力於提供全面並基於科研的產(chǎn)品選擇,以滿足用家的不同需要。我們相信自信的力量,並一直將消費(fèi)者放在首位,憑藉多年在美學(xué)領(lǐng)域的深耕與創(chuàng)新探索,讓他們做出理性的美學(xué)選擇,開啟更加自信的人生。我們恪守對(duì)卓越的承諾,為客戶提供優(yōu)質(zhì)的創(chuàng)新產(chǎn)品、培訓(xùn)教育和專業(yè)服務(wù),向客戶傳遞信心。

傳媒查詢 :




Allergan Aesthetics

Ms Mabel Chan

mabel.chan@allergan.com

2610 5823

MAXLYTICS Limited

Ms Fiona Cheung

info@maxlytics.io

3709 2787

 

^Based on a search of published clinical studies of injectable HA treatments in March 2023. A duration of 9 months of skin hydration was established with SKINVIVE?.11

* Skin hydration was measured using the MoistureMeterD instrument with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively).10

?Instrument measures of skin hydration, smoothness, and skin deformation parameters were performed on the cheek, forehead, and neck of one side of the face on Day 0 and at 30 days after initial treatment (before touch up), Months 1, 4, 6, and 9 after the last treatment, and Month 1R. Skin hydration was measured using the MoistureMeterD instrument (n=131) with the XS 5 and S 15 probes (depth of effective measurement: 0.5 and 1.5 mm, respectively) and top-up treatment administered at Day 30 (n=31). 10

§Lasting up to 9 months as reported by 63% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how radiant their facial skin looked.1

‖ Lasting up to 9 months as reported by 55.1% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how smooth their facial skin looked.1

**Lasting up to 9 months as reported by 55.9% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how their pores looked.1

¶ Lasting up to 9 months as reported by 67.7% of patients. As reported by patients (127/131; 3 subjects did not respond) in a composite satisfaction score, which includes satisfaction with their skin's tone (colour).1

?Lasting up to 9 months as reported by 64.6% of patients. As reported by patients (127/131) in a composite satisfaction score, which includes how clear their facial skin looked.1

??Subjects completed the FACE-Q Satisfaction With Skin scale at baseline (Day 0, before treatment), Months 1, 4, 6, and 9 (before repeat treatment, if received), and Month 1 after the repeat treatment (n=131; n=62 received repeat treatment). The Satisfaction With Skin scale is a validated patient-reported outcome instrument designed to assess the impact of treatment from the subject's perspective. The scale comprises 12 questions about satisfaction with different facial skin attributes (e.g. smoothness, clearness, radiance). Responses are rated on a 4-point scale (1: very dissatisfied, 4: very satisfied). Scores for each item.1

 

References:
1. Ogilvie P et al. J Cosmet Dermatol. 2020;19(5):1065–1070

2. Clin Cosmet Investig Dermatol. 2022 Mar 10;15:411–426

3. SKINVIVE® by Juvéderm® is FDA approved. U.S. Food and Drug Administration, Department of Health & Human Services. SKINVIVE by Juvéderm approval letter P110033/S059, May 2023. 

4. SKINVIVE® by Juvéderm® is CE approved. European Commission, hyaluronic acid based medical devices. EC certificate number: 3824296CE05

5. Allergan Aesthetics. Data on File. REF-108642. JUVÉDERM®, the world's leading brand of hyaluronic acid facial fillers claim. Mar 2023.

6. Allergan Unpublished Data. INT-VOT-2050006. Juvederm VOLITE laboratory testing: hydration and elasticity, mouldability, tissue integration, spreadability. May 2020.

7. Purnamawati S et al. Clin Med Res. 2017;15(3-4);75–87

8. Akinbiyi T et al. Plast Reconstr Surg Glob Open. 2020;8(10):e2763.

9. Lipko-Godlewska S et al. Clin Cosmet Investig Dermatol. 2021;14:169–178.

10. Niforos F et al. Clin Cosmet Investig Dermatol. 2019;12:791–798.

11. SKINVIVE® by Juvéderm® DFU. 20074348. Revision 2022.09.30.

12. Safa M et al. Clin Cosmet Investig Dermatol. 2022;15:411–426.

13. Draelos Z. J Clin Aesthet Dermatol. 2012;5(7):53–56.

14. Allergan Aesthetics. Unpublished data. SKINVIVE? by JUVE?DERM® – 9-month duration of skin hydration in clinical trials. March 2023.

15. Allergan Aesthetics. Unpublished data. SKINVIVE? time of injection. REF-116636. October 2023.

 

SKINVIVE® by Juvéderm® (Hyaluronic Acid Gel with Lidocaine). All adverse events should be reported to MedDeviceComplaintsAPAC@abbvie.com.

Allergan Hong Kong Limited. 香港北角電氣道 183 號(hào)友邦廣場(chǎng) 24 樓 2404 室; 電話: (852)26102525. ©2025 Allergan Aesthetics. All rights reserved. HK-SKV-250035 | 20/MAY/25

消息來(lái)源: Allergan Aesthetics
from common-pcom:html:key:hk_segment_includes_releases_right_column_video_module_shtml
精選視頻
數(shù)據(jù)顯示視頻、圖片等元素讓新聞稿點(diǎn)擊量提升77%
 

化妝品與個(gè)人護(hù)理 最近新聞稿

健康護(hù)理與醫(yī)院 最近新聞稿

日用品 最近新聞稿

新產(chǎn)品/新服務(wù) 最近新聞稿

from common-pcom:html:key:hk_segment_includes_overall_segment_footer_shtml
進(jìn)階搜尋
搜尋
  
  1. 產(chǎn)品與服務(wù)
  2. 新聞稿中心
  3. 知識(shí)庫(kù)
  4. 博客
  5. 多媒體新聞稿
  6. 聯(lián)繫我們
  7. 繁體中文知識(shí)庫(kù)正在建設(shè)中,請(qǐng)您選擇簡(jiǎn)體中文或英文版查看。

  1. 關(guān)於美通社
  2. 聯(lián)繫我們
  3. Legal
  4. Privacy Policy
  5. 加入我們
  6. 網(wǎng)站地圖
  7. RSS訂閱

Copyright © 2025 美通社版權(quán)所有,未經(jīng)許可不得轉(zhuǎn)載.
Cision 旗下公司.

  1. 新聞稿發(fā)佈
  2. 媒體監(jiān)測(cè)和情報(bào)
  3. 信息披露和投資者傳播
  4. 傳播優(yōu)化與增值
  5. 客戶 FAQ
  1. 記者登入 / 註冊(cè)
  2. 專家登入 / 註冊(cè)
  3. 企業(yè)登錄
  1. 美國(guó)
  2. 巴西
  3. 加拿大
  4. 歐洲
  5. 法國(guó)
  6. 以色列
  7. 墨西哥
  8. 荷蘭
  9. 英國(guó)